SPOTLIGHT: Iraqi-bribe probe touches Glaxo, AZ

The feds are shining a spotlight on drug makers suspected of bribing Saddam Hussein's regime. Allegedly, the pharma companies wanted a piece of the oil-for-food action, which allowed petrol money to pay for humanitarian goods--such as drugs. GlaxoSmithKline and AstraZeneca are among those asked for documents related to those sales; the companies deny wrongdoing. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.